OCT can characterize corneoscleral junction

Article

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to newly published research.

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to research published in Optometry and Vision Science.

The novel, quantitative method used by the researchers also established differences among quadrants of the ocular surface, and between ethnic groups.

The researchers recruited a total of 48 subjects (16 Asian, 16 White and 16 Latino), and took OCT images in both eyes of the subjects' nasal, temporal, superior and inferior quadrants. Custom image analysis software allowed selection of a point defining the centre of the corneoscleral junction, and 20 concentric circles were drawn from this point. Edge-detection routines located the surface of the junction, and a linear regression was fit to the series of points that defined the circles intersecting this edge. A set of metrics was then calculated based on the regression residuals.

The researchers found that the most repeatable metric was the sum of the squared orthogonalized residuals (SSRo). In addition, this metric was unaffected by the orientation of the image.

The SSRo was greatest (indicating a more pronounced angle and/or rougher surface) in the nasal quadrant (p p

To read an abstract of the study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.